ND0801

· NeuroDerm Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ND0801, covering 2019-12-05 to 2019-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 1, Phase 2]